Back

Scalable, high-purity isolation of blood extracellular vesicles via a cleavable DNA-lipid anchor

Zhang, S. J.; Fu, R.; Jiang, Z.; Wang, S.-C.; Lewandowski, M.; Krishnan, Y. J.; Walt, D. R.

2025-10-01 pathology
10.1101/2025.09.29.25336888 medRxiv
Show abstract

Extracellular vesicles (EVs) provide a protected molecular record of disease activity, but their potential as blood-based biomarkers has been limited by isolation methods that are slow, impure, and poorly scalable. We developed a cleavable DNA-lipid anchor (cDLA) that reframes EV isolation as a modular chemistry platform, enabling rapid, economical bead-based capture and release of intact vesicles. In plasma, cDLA achieved markedly higher purity than size-exclusion chromatography, delivering deeper proteomic coverage. We applied the approach to uncover vesicular tau signals that more faithfully tracked with cerebrospinal fluid, improving diagnostic discrimination over bulk plasma tau. cDLA provides a robust and clinically scalable method for EV isolation, opening a path to liquid biopsy in neurodegenerative diseases and beyond.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.